Canadian High-tech Advanced Electrophoresis Solutions Ltd. secured a GCI-led investment to expand its business in the biopharmaceutical industry
, / PRNewswire / – High-tech Advanced Electrophoresis Solutions Ltd. (AES) based in Cambridge secured a pre-A investment that closed in April to address critical QA / QC bottlenecks at Biopharma. This round was the first AES institutional growth, led by GCI Capital and Celtic House Asia Partners of Toronto. GCI Capital provided strategic advice through its subsidiary G-Force Innovation Hub to help AES accelerate its sales in the global marketplace. Founded in 2010 by Dr. Tiemin Huang, Advanced Electrophoresis Solutions Ltd. becomes a complete provider of iCIEF technology solutions serving the biopharmaceutical and protein chemistry industries. Dr. Huang hasRead News